The IDIAP Jordi Gol
Who we are
Organization
Directory
Quality Certification
Strategic plan
Annual reports
Work with us
HRS4R
Transparency
Research
Territorial Support Units (USR)
Call Ajuts ICS/IDIAP 2025
Research Areas
Publications
Projects
Featured research projects
European Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Platforms
AGICAP
Sidiap Database
Clinical Trial
Services
Grants to Finance Research
Platforms Questionnaires
Real World Lab
Training
Ongoing training activities
Trainning Plan
Training Placements
IDIAP Conferences
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Link GIR
Acces GIR
Login
Català
Castellano
English
The IDIAP Jordi Gol
Who we are
Organization
Directory
Quality Certification
Strategic plan
Annual reports
Work with us
HRS4R
Transparency
Research
Territorial Support Units (USR)
Call Ajuts ICS/IDIAP 2025
Research Areas
Publications
Projects
Featured research projects
European Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Platforms
AGICAP
Sidiap Database
Clinical Trial
Services
Grants to Finance Research
Platforms Questionnaires
Real World Lab
Training
Ongoing training activities
Trainning Plan
Training Placements
IDIAP Conferences
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Link GIR
Search
Most popular
COL·LABORA
Menu
English
Català
Español
Home
Àrees Recerca
HEALTH SERVICES RESEARCH
GRenSSAP
GRenSSAP
Grup de recerca en Investigació en Serveis
Group leader
Anna Berenguera Ossó
aberenguera@idiapjgol.org
Presentation
Team
Publications
Projects
News
Presentation
Team
Publications
Projects
News
Projects
Group projects
APP FARMACS EMBARAS
Principal investigators:
Maria Giner Soriano
Code:
9F-0-00021-25
Start year:
2025
Post-authorisation safety study to evaluate the utilisation and safety of atogepant in patients with migraine and significant cardiovascular and/or cerebrovascular disease in European countries
Principal investigators:
Talita Duarte Salles
Code:
4RNC-0-00113-24
Start year:
2025
Funders:
Pharmo Institute N.V.
Atlas de prescripción farmacéutica en Diabetes
Principal investigators:
Anna Moleras Serra, Anna Berenguera Ossó
Code:
4RNC-0-00238-24
Start year:
2025
Atlas para la monitorización de los cuidados en Diabetes
Principal investigators:
Anna Moleras Serra, Anna Berenguera Ossó
Code:
4RNC-0-00270-24
Start year:
2025
European non-interventional post-authorization safety study to evaluate cardiovascular events in patients newly exposed to abaloparatide or teriparatide
Principal investigators:
Talita Duarte Salles
Code:
4RNC-0-00322-25
Start year:
2026
Funders:
University of Oxford
Anterior
1
…
22
23
24
25
26
27
Següent
Board of Trustees
Collaborators
Accreditations